Exact Sciences Catapults, Breaking Out, On Rumored Abbott LaboratoriesInvestors Business Daily • 11/19/25
Exact Sciences Corporation (EXAS) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/18/25
Exact Sciences Corporation (EXAS) Presents at 7th Annual Healthcare Symposium TranscriptSeeking Alpha • 11/15/25
Is Exact Sciences (EXAS) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 11/10/25
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome's Blood-Based Colorectal Cancer Screening TestsBusiness Wire • 11/10/25
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance TestBusiness Wire • 11/07/25
Earnings Estimates Rising for Exact Sciences (EXAS): Will It Gain?Zacks Investment Research • 11/05/25
Exact Sciences (EXAS) is an Intriguing Medical Stock to Watch After Q3 EarningsZacks Investment Research • 11/05/25
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 ResultsBenzinga • 11/04/25
Exact Sciences Flirts With A Breakout On Guidance Hike, Sales BeatInvestors Business Daily • 11/03/25
Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/27/25
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening GapsBusiness Wire • 10/27/25
Is Exact Sciences (EXAS) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 10/23/25
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-TermZacks Investment Research • 10/20/25